Doctor profile · Federal record
Dr. MICHELE FARBER, MD
Dermatology Physician (CMS: DERMATOLOGY) · Internal Medicine Physician · Student in an Organized Health Care Education/Training Program · NEW YORK, NY
- NPI 1497016596
- Accepts Medicare
- MIPS 82.2 / 100 · 2023
- 14 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
35 E 35TH ST RM 208
NEW YORK, NY 100163823
(212) 684-5964
Credentials & registration
- NPI registered
- June 2012 — 14 yrs on file
- Profile last updated
- January 6, 2017
- Year of graduation
- 2012 — 14 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State licenses (2)
- New York #283935 · Pennsylvania #MT202086
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1497016596. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,788
Distinct HCPCS
10
Medicare allowed
$97,770
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 719 | 113 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 386 | 312 | $94 | |
17000 |
Destruction of precancer skin growth, 1 growth | 205 | 159 | $57 | |
11102 |
Biopsy of related skin growth, first growth | 121 | 105 | $101 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 87 | 87 | $117 | |
17110 |
Destruction of skin growth, 1-14 growths | 80 | 71 | $121 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 57 | 55 | $59 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 36 | 19 | $1 | |
11103 |
Biopsy of related skin growth, each additional growth | 25 | 22 | $53 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 24 | 18 | $133 |
In context: peer comparison
Among 139 peers in this city , average services per provider: 182. This provider delivers 9.8× the peer median.Open Payments
Industry payments received
All-time total
$1,040
Transactions
61
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 16 | $280.74 | |
| Dermavant Sciences, Inc. | 18 | $183.32 | |
| Novartis Pharmaceuticals Corporation | 5 | $90.53 | |
| Janssen Biotech, Inc. | 3 | $80.52 | |
| Incyte Corporation | 3 | $71.85 | |
| Verrica Pharmaceuticals Inc. | 2 | $61.24 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $55.19 | |
| LEO Pharma Inc. | 3 | $55.00 | |
| GENZYME CORPORATION | 2 | $45.71 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $37.92 | |
| Amgen Inc. | 1 | $32.54 | |
| Arcutis Biotherapeutics, Inc. | 2 | $30.52 | |
| STRATA Skin Sciences, Inc. | 1 | $14.69 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
417
Patients
243
Total drug cost
$39,491
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 107 | 95 | $801 |
| Clobetasol Propionate | Generic | 87 | 55 | $4,773 |
| Ketoconazole | Generic | 61 | 33 | $1,027 |
| Tacrolimus | Generic | 43 | 22 | $5,570 |
| Betamethasone Dipropionate | Generic | 34 | 0 | $2,173 |
| Ammonium Lactate | Generic | 21 | 12 | $367 |
| Doxycycline Hyclate | Generic | 19 | 0 | $399 |
| Hydrocortisone | Generic | 19 | 15 | $213 |
| Clindamycin Phosphate | Generic | 15 | 11 | $766 |
| Opzelura (Ruxolitinib Phosphate) | Brand | 11 | 0 | $23,402 |